Emmessar Biotech Q2 FY27 Results: PAT Rises 23% YoY to Rs 14.03 Lakh
Emmessar Biotech & Nutrition Ltd 路 Financial Result 路 31 Oct 2026, 9:31 pm
Emmessar Biotech Q2 FY27 Results: PAT Rises 23% YoY to Rs 14.03 Lakh Emmessar Biotech & Nutrition reported revenue from operations of Rs 10.92 lakh for Q2 ended 30th Sep'26, up 19.1% YoY from Rs 9.17 lakh (Rs 5.93 lakh in Q1). Total income stood at Rs 62.50 lakh versus Rs 63.04 lakh YoY, supported by other income of Rs 51.58 lakh. PBT rose 23.1% YoY to Rs 17.26 lakh, while net profit grew 23.1% YoY to Rs 14.03 lakh from Rs 11.40 lakh. Basic and diluted EPS improved to Rs 0.28.
Original exchange filing (PDF)
More announcements from Emmessar Biotech & Nutrition Ltd
- please refer attachment 路 02 Nov 2026
- Please refer attachment. 路 31 Oct 2026
- Emmessar Biotech & Nutrition Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/10/2026 ,inter alia, to consider and approve Please refer attachment 路 31 Oct 2026
- Please refer attachment 路 02 Oct 2026
- Please refer attachement 路 29 Sept 2026
- Please refer attachment 路 29 Sept 2026
- Please refer attachment 路 05 Sept 2026
- Please refer attachment 路 04 Sept 2026
